022 Currently News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-- ASC42 has completed Phase I trials in the U.S. and China. This approval from U.S. FDA enables Gannex to complete a critical drug-drug interaction (DDI) study to support upcoming Phase III trials in China, the U.S. and European Union -- Gannex expects to complete this DDI study at the beginning of Q4, 2022 -- Currently, Phase II clinical trial of FXR agonist ASC 42 in China is in progress. Gannex intends to start Phase III clinical trials in China, the U.S. and European Union after the completion of the Phase II clinical trial which is ongoing in China SHANGHAI, June 8, 2022 /PRNewswire/ -- ...

COVID-19 VAX. Eight-year-old Julliu Marco Remes gets his first dose of Covid-19 vaccine during the launch of the pediatric inoculation in Barangay Idio, Sebaste on Monday (Feb. 21, 2022). Currently, 1,230 kids from 5-11 years old in Antique have received their first dose of the Pfizer Covid-19 vaccine.(Photo courtesy of Antique Liga ng mga Barangay) SAN JOSE DE BUENAVISTA, Antique - The Antique Integrated Provincial Health Office (IPHO) has recorded 1,230 kids from 5-11 years old who availed of the coronavirus disease 2019 (Covid-19) vaccination in the province. IPHO information officer Irene ...